Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Combined Exposure of Activated Intestinal Epithelial Cells to Nondigestible Oligosaccharides and CpG-ODN Suppresses Th2-Associated CCL22 Release While Enhancing Galectin-9, TGFβ, and Th1 Polarization.

Overbeek SA, Kostadinova AI, Boks MA, Hayen SM, de Jager W, Van't Land B, Knippels LM, Garssen J, Willemsen LEM.

Mediators Inflamm. 2019 Jul 25;2019:8456829. doi: 10.1155/2019/8456829. eCollection 2019.

2.

Subcutaneous immunotherapy using modified Phl p5a-derived peptides efficiently alleviates allergic asthma in mice.

Hesse L, Feenstra R, Ambrosini M, de Jager WA, Petersen A, Vietor H, Unger WWJ, van Kooyk Y, Nawijn MC.

Allergy. 2019 May 23. doi: 10.1111/all.13918. [Epub ahead of print] No abstract available.

PMID:
31124150
3.

Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation.

Wienke J, Bellutti Enders F, Lim J, Mertens JS, van den Hoogen LL, Wijngaarde CA, Yeo JG, Meyer A, Otten HG, Fritsch-Stork RDE, Kamphuis SSM, Hoppenreijs EPAH, Armbrust W, van den Berg JM, Hissink Muller PCE, Tekstra J, Hoogendijk JE, Deakin CT, de Jager W, van Roon JAG, van der Pol WL, Nistala K, Pilkington C, de Visser M, Arkachaisri T, Radstake TRDJ, van der Kooi AJ, Nierkens S, Wedderburn LR, van Royen-Kerkhof A, van Wijk F.

Arthritis Rheumatol. 2019 Aug;71(8):1377-1390. doi: 10.1002/art.40881. Epub 2019 Mar 12.

PMID:
30861625
4.

Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.

Ter Haar NM, van Dijkhuizen EHP, Swart JF, van Royen-Kerkhof A, El Idrissi A, Leek AP, de Jager W, de Groot MCH, Haitjema S, Holzinger D, Foell D, van Loosdregt J, Wulffraat NM, de Roock S, Vastert SJ.

Arthritis Rheumatol. 2019 Jul;71(7):1163-1173. doi: 10.1002/art.40865. Epub 2019 May 25.

5.

Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.

Blokland SLM, Hillen MR, van Vliet-Moret FM, Bikker A, de Jager W, Pandit A, Kruize AA, Radstake TRDJ, van Roon JAG.

RMD Open. 2019 Jan 11;5(1):e000772. doi: 10.1136/rmdopen-2018-000772. eCollection 2019.

6.

Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.

van den Hoogen LL, van Roon JAG, Mertens JS, Wienke J, Lopes AP, de Jager W, Rossato M, Pandit A, Wichers CGK, van Wijk F, Fritsch-Stork RDE, Radstake TRDJ.

Ann Rheum Dis. 2018 Dec;77(12):1810-1814. doi: 10.1136/annrheumdis-2018-213497. Epub 2018 Sep 5.

PMID:
30185417
7.

First trimester placental vascularization and angiogenetic factors are associated with adverse pregnancy outcome.

Leijnse JEW, de Heus R, de Jager W, Rodenburg W, Peeters LLH, Franx A, Eijkelkamp N.

Pregnancy Hypertens. 2018 Jul;13:87-94. doi: 10.1016/j.preghy.2018.04.008. Epub 2018 Apr 11.

PMID:
30177079
8.

Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.

Hulshof L, Overbeek SA, Wyllie AL, Chu MLJN, Bogaert D, de Jager W, Knippels LMJ, Sanders EAM, van Aalderen WMC, Garssen J, Van't Land B, Sprikkelman AB; Clinical Study Group.

Front Immunol. 2018 Mar 29;9:630. doi: 10.3389/fimmu.2018.00630. eCollection 2018.

9.

Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis.

Ter Haar NM, Tak T, Mokry M, Scholman RC, Meerding JM, de Jager W, Verwoerd A, Foell D, Vogl T, Roth J, Leliefeld PHC, van Loosdregt J, Koenderman L, Vastert SJ, de Roock S.

Arthritis Rheumatol. 2018 Jun;70(6):943-956. doi: 10.1002/art.40442. Epub 2018 May 7.

10.

Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults.

Keustermans GC, Kofink D, Eikendal A, de Jager W, Meerding J, Nuboer R, Waltenberger J, Kraaijeveld AO, Jukema JW, Sels JW, Garssen J, Prakken BJ, Asselbergs FW, Kalkhoven E, Hoefer IE, Pasterkamp G, Schipper HS.

Sci Rep. 2017 Dec 4;7(1):16826. doi: 10.1038/s41598-017-17195-3.

11.

Effect of anticoagulants on 162 circulating immune related proteins in healthy subjects.

Scholman RC, Giovannone B, Hiddingh S, Meerding JM, Malvar Fernandez B, van Dijk MEA, Tempelman MJ, Prakken BJ, de Jager W.

Cytokine. 2018 Jun;106:114-124. doi: 10.1016/j.cyto.2017.10.021. Epub 2017 Oct 28.

12.

Differential adipokine receptor expression on circulating leukocyte subsets in lean and obese children.

Keustermans G, van der Heijden LB, Boer B, Scholman R, Nuboer R, Pasterkamp G, Prakken B, de Jager W, Kalkhoven E, Janse AJ, Schipper HS.

PLoS One. 2017 Oct 26;12(10):e0187068. doi: 10.1371/journal.pone.0187068. eCollection 2017.

13.

Proteomics to predict the response to tumour necrosis factor-α inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score.

Cuppen B, Fritsch-Stork R, Eekhout I, de Jager W, Marijnissen AC, Bijlsma J, Custers M, van Laar JM, Lafeber F, Welsing P; all Society for Rheumatology Research Utrecht (SRU) investigators.

Scand J Rheumatol. 2018 Jan;47(1):12-21. doi: 10.1080/03009742.2017.1309061. Epub 2017 Jun 26.

PMID:
28650254
14.

Proteins in Preservation Fluid as Predictors of Delayed Graft Function in Kidneys from Donors after Circulatory Death.

van Balkom BWM, Gremmels H, Ooms LSS, Toorop RJ, Dor FJMF, de Jong OG, Michielsen LA, de Borst GJ, de Jager W, Abrahams AC, van Zuilen AD, Verhaar MC.

Clin J Am Soc Nephrol. 2017 May 8;12(5):817-824. doi: 10.2215/CJN.10701016.

15.

Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study.

Daan NM, Koster MP, de Wilde MA, Dalmeijer GW, Evelein AM, Fauser BC, de Jager W.

PLoS One. 2016 Nov 2;11(11):e0165033. doi: 10.1371/journal.pone.0165033. eCollection 2016.

16.

Epac1 links prostaglandin E2 to β-catenin-dependent transcription during epithelial-to-mesenchymal transition.

Jansen SR, Poppinga WJ, de Jager W, Lezoualc'h F, Cheng X, Wieland T, Yarwood SJ, Gosens R, Schmidt M.

Oncotarget. 2016 Jul 19;7(29):46354-46370. doi: 10.18632/oncotarget.10128.

17.

APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients.

Barberá A, Lorenzo N, van Kooten P, van Roon J, de Jager W, Prada D, Gómez J, Padrón G, van Eden W, Broere F, Del Carmen Domínguez M.

Cell Stress Chaperones. 2016 Jul;21(4):735-44. doi: 10.1007/s12192-016-0698-0. Epub 2016 May 30.

18.

Inflammatory mediators in human epilepsy: A systematic review and meta-analysis.

de Vries EE, van den Munckhof B, Braun KP, van Royen-Kerkhof A, de Jager W, Jansen FE.

Neurosci Biobehav Rev. 2016 Apr;63:177-90. doi: 10.1016/j.neubiorev.2016.02.007. Epub 2016 Feb 11. Review.

PMID:
26877106
19.

Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis.

Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, Radstake TR, de Boer JH.

Arthritis Rheumatol. 2016 Jul;68(7):1769-79. doi: 10.1002/art.39621.

20.

Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes.

van der Torren CR, Verrijn Stuart AA, Lee D, Meerding J, van de Velde U, Pipeleers D, Gillard P, Keymeulen B, de Jager W, Roep BO.

PLoS One. 2016 Jan 11;11(1):e0146649. doi: 10.1371/journal.pone.0146649. eCollection 2016.

21.

Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome.

van den Munckhof B, de Vries EE, Braun KP, Boss HM, Willemsen MA, van Royen-Kerkhof A, de Jager W, Jansen FE.

Epilepsia. 2016 Feb;57(2):e45-50. doi: 10.1111/epi.13274. Epub 2015 Dec 14.

22.

The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.

Kassa D, de Jager W, Gebremichael G, Alemayehu Y, Ran L, Fransen J, Wolday D, Messele T, Tegbaru B, Ottenhoff TH, van Baarle D.

Tuberculosis (Edinb). 2016 Jan;96:131-40. doi: 10.1016/j.tube.2015.05.015. Epub 2015 Sep 30.

PMID:
26631832
23.

Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discovery.

McArdle A, Qasim Butt A, Szentpetery A, de Jager W, de Roock S, FitzGerald O, Pennington SR.

Proteomics Clin Appl. 2016 Jun;10(6):691-8. doi: 10.1002/prca.201500046. Epub 2015 Nov 9.

PMID:
26332844
24.

Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy.

Vlam L, Stam M, de Jager W, Cats EA, van den Berg LH, van der Pol WL.

J Neuroimmunol. 2015 Sep 15;286:1-4. doi: 10.1016/j.jneuroim.2015.06.008. Epub 2015 Jun 20.

25.

Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.

Holzinger D, Fassl SK, de Jager W, Lohse P, Röhrig UF, Gattorno M, Omenetti A, Chiesa S, Schena F, Austermann J, Vogl T, Kuhns DB, Holland SM, Rodríguez-Gallego C, López-Almaraz R, Arostegui JI, Colino E, Roldan R, Fessatou S, Isidor B, Poignant S, Ito K, Epple HJ, Bernstein JA, Jeng M, Frankovich J, Lionetti G, Church JA, Ong PY, LaPlant M, Abinun M, Skinner R, Bigley V, Sachs UJ, Hinze C, Hoppenreijs E, Ehrchen J, Foell D, Chae JJ, Ombrello A, Aksentijevich I, Sunderkoetter C, Roth J.

J Allergy Clin Immunol. 2015 Nov;136(5):1337-45. doi: 10.1016/j.jaci.2015.04.016. Epub 2015 May 27.

26.

Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors.

Kranendonk ME, van Herwaarden JA, Stupkova T, de Jager W, Vink A, Moll FL, Kalkhoven E, Visseren FL.

Atherosclerosis. 2015 Apr;239(2):419-27. doi: 10.1016/j.atherosclerosis.2015.01.035. Epub 2015 Feb 2.

PMID:
25682042
27.

[Marjolin ulcer; malignant degeneration in a chronic wound].

de Jager WC, Walbeehm ET, Wagner T, Gerritsen MJ.

Ned Tijdschr Geneeskd. 2015;159:A8203. Dutch.

PMID:
25654683
28.

Screening for thyroid dysfunction and diabetes in patients with carpal tunnel syndrome.

Vashishtha M, Varghese B, Mosley F, Kadakia A, de Jager W.

Surgeon. 2016 Jun;14(3):147-9. doi: 10.1016/j.surge.2014.11.003. Epub 2014 Dec 19.

PMID:
25533047
29.

Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis.

van den Broek T, Hoppenreijs E, Meerding J, Scholman R, Otten HG, Swart JF, Martini A, Prakken B, de Jager W.

Ann Rheum Dis. 2015 Feb;74(2):470-2. doi: 10.1136/annrheumdis-2014-206424. Epub 2014 Nov 10. No abstract available.

PMID:
25384964
30.

Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells.

Kranendonk ME, Visseren FL, van Herwaarden JA, Nolte-'t Hoen EN, de Jager W, Wauben MH, Kalkhoven E.

Obesity (Silver Spring). 2014 Oct;22(10):2216-23. doi: 10.1002/oby.20847. Epub 2014 Jul 17.

31.

Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.

Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM.

Arthritis Rheumatol. 2014 Apr;66(4):1034-43. doi: 10.1002/art.38296.

32.

Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis.

Bellutti Enders F, van Wijk F, Scholman R, Hofer M, Prakken BJ, van Royen-Kerkhof A, de Jager W.

Arthritis Rheumatol. 2014 Aug;66(8):2281-9. doi: 10.1002/art.38676.

33.

Interleukin-7 and Toll-like receptor 7 induce synergistic B cell and T cell activation.

Bikker A, Kruize AA, van der Wurff-Jacobs KM, Peters RP, Kleinjan M, Redegeld F, de Jager W, Lafeber FP, van Roon JA.

PLoS One. 2014 Apr 16;9(4):e94756. doi: 10.1371/journal.pone.0094756. eCollection 2014.

34.

TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T Cell repertoire.

Van Rhijn I, Gherardin NA, Kasmar A, de Jager W, Pellicci DG, Kostenko L, Tan LL, Bhati M, Gras S, Godfrey DI, Rossjohn J, Moody DB.

J Immunol. 2014 May 1;192(9):4054-60. doi: 10.4049/jimmunol.1400158. Epub 2014 Mar 28.

35.

Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment.

Delemarre EM, Roord ST, van den Broek T, Zonneveld-Huijssoon E, de Jager W, Rozemuller H, Martens AC, Broere F, Wulffraat NM, Glant TT, Prakken BJ, van Wijk F.

Arthritis Rheumatol. 2014 Feb;66(2):350-6. doi: 10.1002/art.38261.

36.

T cell recognition of naturally presented epitopes of self-heat shock protein 70.

de Jong H, Koffeman EC, Meerding JM, Scholman RC, Wieten L, de Jager W, Klein M, Otten H, van Wijk F, van der Zee R, Bijlsma JW, Broere F, van Eden W, Prakken BJ.

Cell Stress Chaperones. 2014 Jul;19(4):569-78. doi: 10.1007/s12192-013-0484-1. Epub 2014 Jan 15.

37.

Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages.

Kranendonk ME, Visseren FL, van Balkom BW, Nolte-'t Hoen EN, van Herwaarden JA, de Jager W, Schipper HS, Brenkman AB, Verhaar MC, Wauben MH, Kalkhoven E.

Obesity (Silver Spring). 2014 May;22(5):1296-308. doi: 10.1002/oby.20679. Epub 2014 Jan 9.

38.

Plasma IL-25 is elevated in a subgroup of patients with clinical reactivity to peanut.

Aalberse JA, van Thuijl AO, Meijer Y, de Jager W, van der Palen-Merkus T, Sprikkelman AB, Hoekstra MO, Prakken BJ, van Wijk F.

Clin Transl Allergy. 2013 Dec 2;3(1):40. doi: 10.1186/2045-7022-3-40.

39.

Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity.

Moret FM, Hack CE, van der Wurff-Jacobs KM, de Jager W, Radstake TR, Lafeber FP, van Roon JA.

Arthritis Res Ther. 2013 Oct 20;15(5):R155. doi: 10.1186/ar4338.

40.

Qualitative insights into the psychological stress before and during colposcopy: a focus group study.

Bosgraaf RP, de Jager WC, Servaes P, Prins JB, Massuger LF, Bekkers RL.

J Psychosom Obstet Gynaecol. 2013 Dec;34(4):150-6. doi: 10.3109/0167482X.2013.849688.

PMID:
24188786
41.

Plasma chemokines in early wheezers predict the development of allergic asthma.

Reubsaet LL, Meerding J, de Jager W, de Kleer IM, Hoekstra MO, Prakken BJ, van Wijk F, Arets HG.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):1039-40. doi: 10.1164/rccm.201212-2330LE. No abstract available.

PMID:
24127809
42.

Biomarkers in inflammatory childhood diseases.

de Jager W, Holzinger D, Rijkers GT.

Mediators Inflamm. 2013;2013:745493. doi: 10.1155/2013/745493. Epub 2013 Jun 10. No abstract available.

43.

A conserved human T cell population targets mycobacterial antigens presented by CD1b.

Van Rhijn I, Kasmar A, de Jong A, Gras S, Bhati M, Doorenspleet ME, de Vries N, Godfrey DI, Altman JD, de Jager W, Rossjohn J, Moody DB.

Nat Immunol. 2013 Jul;14(7):706-13. doi: 10.1038/ni.2630. Epub 2013 Jun 2.

44.

Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples.

Keustermans GC, Hoeks SB, Meerding JM, Prakken BJ, de Jager W.

Methods. 2013 May 15;61(1):10-7. doi: 10.1016/j.ymeth.2013.04.005. Epub 2013 Apr 19. Review.

PMID:
23603216
45.

Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells.

Haveman LM, Bierings M, Klein MR, Beekman JM, de Jager W, Kuis W, Albani S, Prakken BJ.

Clin Immunol. 2013 Mar;146(3):228-39. doi: 10.1016/j.clim.2013.01.002. Epub 2013 Jan 16.

PMID:
23416239
46.

Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines.

Kan AA, de Jager W, de Wit M, Heijnen C, van Zuiden M, Ferrier C, van Rijen P, Gosselaar P, Hessel E, van Nieuwenhuizen O, de Graan PN.

J Neuroinflammation. 2012 Aug 30;9:207. doi: 10.1186/1742-2094-9-207.

47.

Increased immune reactivity towards human hsp60 in patients with primary Sjögren's syndrome is associated with increased cytokine levels and glandular inflammation.

de Jong H, de Jager W, Wenting-van Wijk M, Prakken BJ, Kruize AA, Bijlsma JW, Lafeber FP, van Roon JA.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4):594-5. Epub 2012 Aug 29. No abstract available.

PMID:
22931585
48.

The effect of the metabolic syndrome on the risk and outcome of coronary artery bypass graft surgery.

Swart MJ, De Jager WH, Kemp JT, Nel PJ, Van Staden SL, Joubert G.

Cardiovasc J Afr. 2012 Aug;23(7):400-4. doi: 10.5830/CVJA-2012-055.

49.

Recognition of self-heat shock protein 60 by T cells from patients with atopic dermatitis.

Kapitein B, Aalberse JA, Klein MR, de Jager W, Hoekstra MO, Knol EF, Prakken BJ.

Cell Stress Chaperones. 2013 Jan;18(1):87-95. doi: 10.1007/s12192-012-0361-3. Epub 2012 Aug 7.

50.

Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes.

Schipper HS, Nuboer R, Prop S, van den Ham HJ, de Boer FK, Kesmir Ç, Mombers IMH, van Bekkum KA, Woudstra J, Kieft JH, Hoefer IE, de Jager W, Prakken B, van Summeren M, Kalkhoven E.

Diabetologia. 2012 Oct;55(10):2800-2810. doi: 10.1007/s00125-012-2641-y. Epub 2012 Jul 18.

PMID:
22806355

Supplemental Content

Loading ...
Support Center